Genmab — Maj 2023
-
Chancerne for at vinde den kørende ankesag, anser jeg for værende stort set 0. Jeg er overbevist om, at Genmab havde været bedst tjent med, at acceptere den første dom i voldgiften. Og indse, at et lille Dansk selskab, ikke har en bønnemands chance for at kanøfle et big pharma selskab på hjemmebane i USA. Og jeg vil være lykkelig for at skulle æde mine egne ord

-
hele denne voldgiftsballade, har, efter min mening, skadet Genmab voldsomt.
-
@bongobob 11:07 Janine Schuurman er ikke mere ansat hos Genmab (bare til info)
-
Winkel har solgt 21000 aktier https://ml-eu.globenewswire.com/Resource/Download/46c5d395-edd1-43ba-a5a2-5c98acd65f46
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind